[EFFECT] InMed Pharmaceuticals Inc. SEC Filing

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

EFFECT

03/31/2026 - 12:15 AM

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	March 30, 2026 5:00 P.M.

Form:

S-3

CIK:	0001728328
Company Name:	InMed Pharmaceuticals Inc.
File Number:	333-294503

Source: View Original Filing on SEC EDGAR

Inmed Pharmaceuticals Inc

NASDAQ:INM

View INM Stock Overview →

INM Rankings

#6982 Ranked by Market Cap

N/A Ranked by Dividends

INM Latest News

Mar 27, 2026

InMed Pharmaceuticals Receives Nasdaq Notification Regarding Minimum Bid Price Compliance

Mar 23, 2026

InMed Pharmaceuticals Announces Positive Data from Human Brain Organoid Neuroinflammation Models Supporting the INM-901 Alzheimer's Disease Program

Mar 9, 2026

InMed Provides Update on Pharmaceutical Development Programs - Advancing Lead Drug Candidates Towards IND and Clinical Trial

Mar 6, 2026

InMed Provides Update on BayMedica Operations and Strengthens Focus on Pharmaceutical Development Pipeline

Feb 11, 2026

InMed Reports Second Quarter Fiscal 2026 Financial Results and Provides Business Update

INM Latest SEC Filings

Mar 30, 2026

[8-K] InMed Pharmaceuticals Inc. Reports Material Event

Mar 23, 2026

[8-K] InMed Pharmaceuticals Inc. Reports Material Event

Mar 20, 2026

[S-3] InMed Pharmaceuticals Inc. Shelf Registration Statement

Mar 9, 2026

[8-K] InMed Pharmaceuticals Inc. Reports Material Event

Mar 6, 2026

[8-K] InMed Pharmaceuticals Inc. Reports Material Event

INM Stock Data

Market Cap 1.80M

Float 2.92M

Industry Drug Manufacturers - Specialty & Generic

Sector Pharmaceutical Preparations

Website Link

Country Canada

City VANCOUVER